Lab Canada

Product News

NMR platform suitable for clinical screening, IVD discovery


Ease-of-use as well as the data quality and reliability are important considers when investing in a system for nuclear magnetic resonance (NMR) spectroscopy. Bruker’s Avance-IVDr is a standardized NMR platform for both clinical and diagnostic users that provides NMR clinical research and screening, as well as IVD-by-NMR research. It features high sensitivity and information-rich output at 600 MHz proton-NMR frequency, and includes capabilities and SOPS for bio-fluid screening and assay validation. It offers barcode analysis, control by  LIMS system, a high-throughput temperature-controlled autosampler, remote access, automatic analysis and customizable analytical results reporting. Bruker Corporation


Print this page

Related